Internal link ProQR Announces Year End 2024 Operating and Financial Results March 13, 2025 at 11:00 AM UTC
Internal link ProQR Announces R&D Day and Provides Update on Innovation Portfolio November 30, 2015 at 12:00 PM UTC
Internal link ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials November 23, 2015 at 11:30 AM UTC
Internal link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences October 01, 2015 at 11:00 AM UTC
Internal link ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable September 23, 2015 at 11:00 AM UTC
Internal link ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment September 14, 2015 at 11:00 AM UTC
Internal link ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients June 26, 2015 at 11:54 AM UTC
Internal link ProQR to Present at the JMP Securities Life Science Conference June 16, 2015 at 11:00 AM UTC
Internal link ProQR Therapeutics Announces Results for the First Quarter of 2015 May 21, 2015 at 11:00 AM UTC
Internal link ProQR to Present at Two Upcoming Investor Conferences in May April 29, 2015 at 11:00 AM UTC
Internal link ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 February 26, 2015 at 12:00 PM UTC
Internal link ProQR to Present at the 2015 Leerink Global Healthcare Conference February 04, 2015 at 12:00 PM UTC